Stock listing
Xetra:NN6 NanoRepro AG Aktie
Home listing (Xetra) of NanoRepro AG
Follow NanoRepro AG into a list and get an email when it puts out news.
Share price · XETR:NN6
€1.41 EUR -0.01 (-1.1%)
Close on Nov 20, 2026
- Day range
- €1.41 – €1.41 EURNov 20, 2026
- Volume
- 1,722 sharesNov 20, 2026
- Market cap
- €17.72M EURAt the close on Nov 20, 2026 · price × 12.61M shares outstanding
- 52-week range
- €1.31 – €2.40 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €12,971 EURMedian day 3,936 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| Xetra:NN6 · Home | €1.405 EUR | -0.015 (-1.1%) | 1,722 | €1.405 | €1.405 | €1.405 | €1.42 | Close on Nov 20, 2026 |
| Frankfurt:NN6 | €1.40 EUR | +0.065 (+4.9%) | — | €1.40 | €1.40 | €1.40 | €1.335 | Close on Nov 20, 2026 |
| Hamburg:NN6 | €1.40 EUR | +0.065 (+4.9%) | — | €1.40 | €1.40 | €1.40 | €1.335 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · XETR:NN6 · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €1.405 | -0.015 | -1.1% | €1.405 | €1.405 | €1.405 | 1,722 | |
| €1.42 | +0.04 | +2.9% | €1.32 | €1.44 | €1.32 | 19,487 | |
| €1.38 | -0.005 | -0.4% | €1.38 | €1.38 | €1.325 | 4,789 | |
| €1.385 | -0.015 | -1.1% | €1.44 | €1.44 | €1.325 | 6,443 | |
| €1.40 | -0.035 | -2.4% | €1.45 | €1.45 | €1.35 | 20,785 | |
| €1.435 | -0.035 | -2.4% | €1.44 | €1.48 | €1.42 | 12,818 | |
| €1.47 | -0.07 | -4.5% | €1.56 | €1.56 | €1.38 | 39,021 | |
| €1.54 | -0.035 | -2.2% | €1.535 | €1.55 | €1.50 | 18,349 | |
| €1.575 | +0.01 | +0.6% | €1.60 | €1.60 | €1.535 | 761 | |
| €1.565 | -0.005 | -0.3% | €1.56 | €1.565 | €1.535 | 11,111 | |
| €1.57 | -0.005 | -0.3% | €1.585 | €1.585 | €1.535 | 3,648 | |
| €1.575 | +0.005 | +0.3% | €1.535 | €1.58 | €1.535 | 3,413 | |
| €1.57 | 0.00 | 0.0% | €1.54 | €1.57 | €1.54 | 1,915 | |
| €1.57 | -0.045 | -2.8% | €1.62 | €1.62 | €1.54 | 2,334 | |
| €1.615 | -0.02 | -1.2% | €1.65 | €1.65 | €1.60 | 1,002 | |
| €1.635 | +0.06 | +3.8% | €1.575 | €1.66 | €1.57 | 28,315 | |
| €1.575 | 0.00 | 0.0% | €1.54 | €1.60 | €1.54 | 4,224 | |
| €1.575 | +0.01 | +0.6% | €1.58 | €1.60 | €1.545 | 2,652 | |
| €1.565 | -0.035 | -2.2% | €1.60 | €1.60 | €1.565 | 4,854 | |
| €1.60 | -0.045 | -2.7% | €1.70 | €1.70 | €1.58 | 12,600 | |
| €1.645 | -0.065 | -3.8% | €1.72 | €1.72 | €1.64 | 2,306 | |
| €1.71 | -0.07 | -3.9% | €1.71 | €1.715 | €1.64 | 1,472 | |
| €1.78 | +0.035 | +2.0% | €1.71 | €1.78 | €1.70 | 1,853 | |
| €1.745 | +0.02 | +1.2% | €1.71 | €1.745 | €1.71 | 150 | |
| €1.725 | -0.005 | -0.3% | €1.72 | €1.74 | €1.66 | 2,433 | |
| €1.73 | -0.07 | -3.9% | €1.745 | €1.745 | €1.68 | 21,642 | |
| €1.80 | +0.04 | +2.3% | €1.76 | €1.80 | €1.715 | 1,292 | |
| €1.76 | -0.03 | -1.7% | €1.75 | €1.78 | €1.68 | 6,463 | |
| €1.79 | +0.06 | +3.5% | €1.72 | €1.79 | €1.695 | 2,810 | |
| €1.73 | -0.005 | -0.3% | €1.74 | €1.80 | €1.73 | 14,725 | |
| €1.735 | +0.04 | +2.4% | €1.745 | €1.80 | €1.735 | 17,247 | |
| €1.695 | +0.045 | +2.7% | €1.75 | €1.75 | €1.64 | 19,616 | |
| €1.65 | +0.015 | +0.9% | €1.635 | €1.695 | €1.635 | 927 | |
| €1.635 | +0.04 | +2.5% | €1.635 | €1.695 | €1.635 | 1 | |
| €1.595 | -0.015 | -0.9% | €1.55 | €1.70 | €1.55 | 18,945 | |
| €1.61 | +0.01 | +0.6% | €1.72 | €1.72 | €1.57 | 1,476 | |
| €1.60 | -0.05 | -3.0% | €1.625 | €1.65 | €1.60 | 1,093 | |
| €1.65 | -0.03 | -1.8% | €1.69 | €1.69 | €1.64 | 15,194 | |
| €1.68 | -0.05 | -2.9% | €1.62 | €1.68 | €1.62 | 1 | |
| €1.73 | +0.01 | +0.6% | €1.72 | €1.73 | €1.655 | 1,622 | |
| €1.72 | +0.085 | +5.2% | €1.655 | €1.72 | €1.655 | 1,653 | |
| €1.635 | -0.08 | -4.7% | €1.675 | €1.715 | €1.595 | 6,760 | |
| €1.715 | -0.02 | -1.2% | €1.715 | €1.715 | €1.675 | 1,885 | |
| €1.735 | +0.02 | +1.2% | €1.74 | €1.74 | €1.735 | 2,710 | |
| €1.715 | +0.015 | +0.9% | €1.705 | €1.73 | €1.675 | 2,710 | |
| €1.70 | -0.035 | -2.0% | €1.675 | €1.705 | €1.675 | 1,195 | |
| €1.735 | +0.04 | +2.4% | €1.74 | €1.74 | €1.675 | 552 | |
| €1.695 | -0.02 | -1.2% | €1.74 | €1.78 | €1.675 | 3,041 | |
| €1.715 | -0.065 | -3.7% | €1.75 | €1.75 | €1.715 | 100 | |
| €1.78 | +0.03 | +1.7% | €1.74 | €1.78 | €1.74 | 1 | |
| €1.75 | -0.055 | -3.0% | €1.755 | €1.755 | €1.725 | 1,275 | |
| €1.805 | +0.14 | +8.4% | €1.68 | €1.805 | €1.68 | 12,844 | |
| €1.665 | -0.07 | -4.0% | €1.75 | €1.75 | €1.65 | 16,383 | |
| €1.735 | +0.01 | +0.6% | €1.75 | €1.81 | €1.68 | 26,210 | |
| €1.725 | +0.035 | +2.1% | €1.77 | €1.84 | €1.685 | 21,942 | |
| €1.69 | -0.005 | -0.3% | €1.68 | €1.735 | €1.68 | 4,836 | |
| €1.695 | -0.045 | -2.6% | €1.74 | €1.76 | €1.64 | 20,345 | |
| €1.74 | 0.00 | 0.0% | €1.74 | €1.74 | €1.74 | 721 | |
| €1.74 | -0.025 | -1.4% | €1.61 | €1.74 | €1.61 | 12,421 | |
| €1.765 | -0.095 | -5.1% | €1.86 | €1.86 | €1.75 | 10,573 | |
| €1.86 | -0.02 | -1.1% | €1.775 | €1.86 | €1.775 | 5,157 | |
| €1.88 | +0.035 | +1.9% | €1.88 | €1.88 | €1.80 | 5,647 | |
| €1.845 | -0.005 | -0.3% | €1.82 | €1.87 | €1.82 | 14,367 | |
| €1.85 | -0.06 | -3.1% | €1.96 | €1.96 | €1.82 | 6,901 | |
| €1.91 | +0.025 | +1.3% | €1.91 | €1.91 | €1.91 | 652 | |
| €1.885 | -0.015 | -0.8% | €1.895 | €1.90 | €1.805 | 8,569 |
Splits
3 splits since 2013 · XETR:NN6 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 52-for-51 | Split | |
| 59-for-57 | Split | |
| 100-for-99 | Split |
- Ticker
- Xetra:NN6
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- Xetra
- Currency
- EUR
What changed lately
Latest news release · Jun 19, 2026
Original-Research: NanoRepro AG (von NuWays AG): BUY
Latest news
Original-Research: NanoRepro AG (von NuWays AG): BUY
Jun 19, 2026
Closed €2.02 (0.0%) on Jun 19, 2026
NanoRepro AG: Dr. Olaf Stiller, buy
May 29, 2026
Closed €1.83 (+2.8%) on May 29, 2026
NanoRepro AG on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 2 in the last 12 months · 2 in all · newest Jun 19, 2026 · oldest 2026
- Decks
- 4 decks · latest Aug 26, 2025
Where NanoRepro AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Xetra:NN6 · Home listing · This page | Xetra | Germany | EUR |
| Tradegate:NN6 | Tradegate | Germany | EUR |
| gettex:NN6 | gettex | Germany | EUR |
| Frankfurt:NN6 | Frankfurt | Germany | EUR |
| LS Exchange:657710 | LS Exchange | Germany | EUR |
| Stuttgart:NN6 | Stuttgart | Germany | EUR |
| Lang & Schwarz:657710 | Lang & Schwarz | Germany | EUR |
| Dusseldorf:NN6 | Dusseldorf | Germany | EUR |
| Munich:NN6 | Munich | Germany | EUR |
| Hamburg:NN6 | Hamburg | Germany | EUR |
Valuation
Price/book 0.5× against a median of 1.3×: 2nd lowest of 11 Diagnostics & research services companies shown. balance Jun 30, 2025 · price Nov 20, 2026
- Enterprise value
- €10.43M EUR
- P/E
- Not reported
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 0.5×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| NanoRepro AG · XETR:NN6 | US$19.45M | US$11.45M | n/a | n/a | n/a | 0.5× | n/a | 0.0× | n/a |
| GeneReach Biotechnology Corp. · TPEX:4171 | US$21.05M | US$9.04M | n/a | 1.3× | 222× | 1.2× | −18.1% | 0.0× | n/a |
| IVIM Technology, Inc. · KRX:460470 | US$20.68M | US$10.37M | n/a | 2.1× | n/a | 1.1× | −40.9% | 0.0× | n/a |
| Q-linea AB · OMXSTO:QLINEA | US$20.66M | US$7.57M | n/a | 6.9× | n/a | 0.9× | n/a | 0.1× | n/a |
| TFBS Bioscience, Inc. · TPEX:6939 | US$19.81M | US$7.83M | n/a | 1.3× | n/a | 0.6× | −38.6% | 0.0× | n/a |
| SANIGEN Co., Ltd. · KRX:188260 | US$19.66M | US$10.06M | n/a | 2.2× | n/a | 2.3× | −82.6% | 0.1× | n/a |
| Urteste S.A. · GPW:URT | US$19.24M | US$19.10M | n/a | 3,525× | n/a | 3.5× | n/a | 0.0× | n/a |
| Genematrix Inc. · KRX:109820 | US$19.06M | US$6.80M | n/a | 0.8× | 31.7× | 1.4× | −1.7% | 0.0× | n/a |
| Oxford BioDynamics PLC · LSE:OBD | US$18.46M | US$20.77M | n/a | 14.5× | n/a | 4.3× | n/a | 1.3× | n/a |
| RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makina Sanayi Ticaret A.S. · BIST:RTALB | US$18.41M | US$16.94M | 1.1× | 3.6× | 61.6× | 0.3× | 367.8% | 0.0× | n/a |
| Nexsen Limited · ASX:NXN | US$18.05M | US$15.08M | n/a | n/a | n/a | 4.8× | n/a | 0.0× | n/a |
| Median of the others | US$19.45M | US$10.22M | 1.1× | 2.2× | 61.6× | 1.3× | −28.3% | 0.0× |
Forecasts
Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 4.47 EUR · Analysts' mean
- EPS, year to Dec 2026
- -0.15 · 2 analysts
- Revenue, year to Dec 2026
- 18.4M · 2 analysts
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Shareholder Meeting (August 2025) | Shareholder meeting | 35 slides | Aug 26, 2025 |
| Investor Presentation (May 2016) | Investor deck | 36 slides | May 12, 2016 |
| Investor Presentation (February 2015) | Investor deck | 20 slides | February 2015 |
| Shareholder Meeting (April 2014) | Shareholder meeting | 22 slides | Apr 17, 2014 |
Financials
Annual, in EUR
Income statement
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.65M | 3.18M | 38.5M | 162.7M | 16.9M | 1.22M | 2.75M | 1.97M | 1.85M | 607.7K |
| Cost of revenue | 1.70M | 1.35M | 28.6M | 109.0M | 12.3M | 949.3K | 1.14M | 868.5K | 1.05M | 266.8K |
| Gross profit | 2.95M | 1.83M | 9.90M | 53.7M | 4.66M | 269.0K | 1.61M | 1.10M | 799.0K | 340.9K |
| Selling, general and administrative | 1.90M | 1.36M | 1.83M | 2.82M | 1.10M | 748.5K | 745.6K | 806.2K | 657.8K | 691.9K |
| Operating income | -3.62M | -5.34M | -4.53M | 38.8M | 2.80M | -1.18M | -323.4K | -723.6K | -1.10M | -1.18M |
| Depreciation and amortization | 30.8K | 21.0K | 9.20K | 9.57K | 1.87M | 312.2K | 339.0K | 193.0K | 208.8K | 216.8K |
| EBITDA | -3.59M | -5.32M | -4.52M | 38.8M | 4.67M | -869.2K | 15.6K | -530.6K | -895.5K | -958.7K |
| Interest expense | 105.0K | 105.0K | 773 | 52.4K | 18.3K | 7.48K | 7.59K | 10.4K | 4.91K | 1.15K |
| Income before tax | -2.74M | -4.68M | -4.36M | 38.8M | 2.78M | -1.19M | -330.6K | -733.9K | -1.11M | -1.18M |
| Income tax | -692.7K | 984 | -640.2K | 9.03M | 1.09M | 119 | -41.0K | 190 | -557.0K | -283 |
| Net income | -2.05M | -4.69M | -3.72M | 29.7M | 1.69M | -1.19M | -289.6K | -734.1K | -551.7K | -1.18M |
| Earnings per share, basic | -0.16 | -0.37 | -0.29 | 2.30 | 0.18 | -0.14 | -0.03 | -0.11 | -0.10 | -0.27 |
Balance sheet
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 9.10M | 16.6M | 31.3M | 28.0M | 1.16M | 737.2K | 1.77M | 528.1K | 530.1K | 230.5K |
| Short-term investments | 4.02M | |||||||||
| Receivables | 545.8K | 6.25M | 8.73M | 32.5M | 7.32M | 450.9K | 603.5K | 331.6K | 31.1K | 35.8K |
| Inventory | 901.4K | 603.9K | 1.62M | 17.9M | 2.57M | 569.2K | 677.8K | 735.1K | 422.8K | 403.3K |
| Current assets | 15.0M | 35.3M | 46.0M | 79.0M | 11.1M | 1.82M | 3.13M | 1.66M | 1.05M | 794.3K |
| Property, plant and equipment | 347.4K | 50 | 320 | 592 | 750 | 3.03K | 6.39K | 10.7K | 13.3K | 20.5K |
| Goodwill | 0 | |||||||||
| Total assets | 39.0M | 41.5M | 49.5M | 79.1M | 11.2M | 4.80M | 5.81M | 4.20M | 3.51M | 2.44M |
| Accounts payable | 216.1K | 170.0K | 371.2K | 1.99M | 358.7K | 116.2K | 94.9K | 81.6K | 167.2K | 73.6K |
| Current liabilities | 299.5K | 673.4K | 1.10M | 11.0M | 2.20M | 351.2K | 120.5K | 291.1K | 347.9K | 92.7K |
| Long-term debt | 0 | 150.0K | 23 | 5.97K | 5.97K | 13.5K | ||||
| Total debt | 150.0K | 1.35M | 198.2K | 238 | 135.9K | 156.0K | 13.5K | |||
| Total liabilities | 884.0K | 1.08M | 2.04M | 21.5M | 3.18M | 374.2K | 188.1K | 373.3K | 478.8K | 164.6K |
| Shareholders' equity | 38.1M | 40.4M | 47.4M | 57.6M | 7.99M | 4.43M | 5.62M | 3.82M | 3.03M | 2.27M |
| Shares outstanding | 12.6M | 12.7M | 12.9M | 12.9M | 9.33M | 8.65M | 8.48M | 6.84M | 5.65M | 4.34M |
Cash flow
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 9.86M | -10.3M | 13.1M | 8.16M | -1.12M | -612.4K | -257.6K | -1.14M | -769.7K | -934.6K |
| Capital spending | -402.6K | 0 | -3.31M | -1.40K | -500 | -618.0K | -441.3K | -3.80K | -800 | -1.60K |
| Free cash flow | 9.46M | -10.3M | 9.84M | 8.16M | -1.12M | -612.4K | -257.6K | -1.15M | -770.5K | -936.2K |
| Cash from investing | -17.2M | -2.03M | -3.31M | -1.40K | -316.8K | -618.1K | -440.9K | -350.1K | -380.4K | -390.0K |
| Cash from financing | -188.8K | -2.37M | -6.60M | 18.7M | 1.87M | 198.0K | 1.94M | 1.49M | 1.45M | 1.44M |
| Dividends paid | -1.93M | -6.45M | ||||||||
| Share buybacks | -188.8K | -438.5K | 0 | 1.52M | 1.31M | 1.54M | ||||
| Change in cash | -7.50M | -14.7M | 3.24M | 26.9M | 426.5K | -1.03M | 1.24M | -2.00K | 299.6K | 231.5K |
Cap table
Built by 6ix from NanoRepro AG’s releases
- Common shares
- 12,613,276
- Fully diluted
- 12,613,276
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 12,613,276 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 12,613,276 |
Log in to ask 6ix AI your own questions about NanoRepro AG.